Biotechnology Progress

Papers
(The H4-Index of Biotechnology Progress is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Dynamic flux balance analysis of 1,3‐propanediol production by clostridium butyricum fermentation82
From protein structure to an optimized chromatographic capture step using multiscale modeling53
Design of experiments‐guided membrane capture facilitates integration of continuous virus inactivation using Phi6 as a surrogate virus in an intensified downstream process51
Proteomics‐based method to comprehensively model the removal of host cell protein impurities33
Optimized pulse‐feeding fed‐batch fermentation for enhanced lignin to polyhydroxyalkanoate transformation30
The effects of the chemical modification on immobilized lipase features are affected by the enzyme crowding in the support29
Acetate accumulation and regulation by process parameters control in Chinese hamster ovary cell culture29
Dynamic pH profiles drive higher cell‐specific and volumetric productivity29
Issue Information27
High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditions27
Pre‐folding purification procedures for inclusion body‐derived non‐tagged cationic recombinant proteins with multiple disulfide bonds for efficient refolding26
A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process25
Depth filtration for clarification of intensified lentiviral vector suspension cell culture24
Exploring the design space for T riton X ‐100 substitutes in viral inactivation applications23
Enrichment of full AAV capsids by preparative strong anion exchange chromatography23
Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus20
Issue Information20
Current status of platelet manufacturing in 3D or bioreactors19
Genetically engineered neural stem cells (NSCs) therapy for neurological diseases; state‐of‐the‐art19
Online monitored characterization of Phocaeicola vulgatus for organic acid production using anaerobic microtiter plate cultivations19
Evaluating multiproduct chromatography Protein A resin reuse for monoclonal antibodies in biopharmaceutical manufacturing19
0.18386077880859